Nexus AG
XETRA:NXU
Intrinsic Value
NEXUS AG engages in the development and sale of software and hardware solutions. [ Read More ]
The intrinsic value of one NXU stock under the Base Case scenario is 56.02 EUR. Compared to the current market price of 51.7 EUR, Nexus AG is Undervalued by 8%.
Valuation Backtest
Nexus AG
Run backtest to discover the historical profit from buying and selling NXU stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Nexus AG
Current Assets | 167.8m |
Cash & Short-Term Investments | 102.5m |
Receivables | 58.4m |
Other Current Assets | 6.9m |
Non-Current Assets | 244m |
Long-Term Investments | 2m |
PP&E | 32.9m |
Intangibles | 204.8m |
Other Non-Current Assets | 4.3m |
Current Liabilities | 86.2m |
Accounts Payable | 8.7m |
Accrued Liabilities | 22.3m |
Other Current Liabilities | 55.2m |
Non-Current Liabilities | 70.4m |
Long-Term Debt | 15.4m |
Other Non-Current Liabilities | 55m |
Earnings Waterfall
Nexus AG
Revenue
|
241.5m
EUR
|
Cost of Revenue
|
-38.4m
EUR
|
Gross Profit
|
203.1m
EUR
|
Operating Expenses
|
-170.3m
EUR
|
Operating Income
|
32.8m
EUR
|
Other Expenses
|
-8.7m
EUR
|
Net Income
|
24m
EUR
|
Free Cash Flow Analysis
Nexus AG
NXU Profitability Score
Profitability Due Diligence
Nexus AG's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Score
Nexus AG's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
NXU Solvency Score
Solvency Due Diligence
Nexus AG's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Score
Nexus AG's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NXU Price Targets Summary
Nexus AG
According to Wall Street analysts, the average 1-year price target for NXU is 69.36 EUR with a low forecast of 65.65 EUR and a high forecast of 74.55 EUR.
Shareholder Return
NXU Price
Nexus AG
Average Annual Return | 25.23% |
Standard Deviation of Annual Returns | 35.63% |
Max Drawdown | -45% |
Market Capitalization | 892.6m EUR |
Shares Outstanding | 17 271 400 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
NEXUS AG engages in the development and sale of software and hardware solutions. The company is headquartered in Donaueschingen, Baden-Wuerttemberg and currently employs 1,469 full-time employees. The company went IPO on 2000-07-24. Among others, the Company provides Nexus/HIS, an information system that supports the administrative and medical/nursing areas in hospitals; Nexus/Obstetrics, a documentation software for pregnancies; is also focusing on digital pathology which controls the processes from material entry to billing; Nexus/Psychiatry, a solution for psychiatric institutions from treating patients to key figure management for institution management; CWD - Clinic WindData (E&L), a diagnostics software for the areas of endoscopy, cardiology, sonography and ophthalmology; Nexus/Home, an information system that features finance, resident and treatment management, as well as staff deployment, and Nexus/Curator, a Web-based knowledge database for quality management with document management in health care. The firm operates through subsidiaries in Austria, France, Spain, Switzerland, the Netherlands and Poland, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one NXU stock under the Base Case scenario is 56.02 EUR.
Compared to the current market price of 51.7 EUR, Nexus AG is Undervalued by 8%.